|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
12/22/2017 |
$0.28 |
$0.28 |
$0.27 |
$0.28 |
730.60K | 12/26/2017 |
$0.28 |
$0.29 |
$0.27 |
$0.28 |
500.30K | 12/27/2017 |
$0.28 |
$0.29 |
$0.27 |
$0.28 |
577.40K | 12/28/2017 |
$0.28 |
$0.28 |
$0.27 |
$0.28 |
705.30K | 12/29/2017 |
$0.29 |
$0.40 |
$0.26 |
$0.26 |
20.35M |
|
SELLAS Life Sciences Group is a biopharmaceutical company developing hematology and oncology therapeutics. Co.'s pipeline consists of multiple mid- to late-stage clinical assets, including its hematology asset, GALE-401, and its cancer immunotherapy programs including NeuVax (nelipepimut-S), GALE-301 and GALE-302. GALE-401 is a controlled release version of the approved drug anagrelide for the treatment of elevated platelets in patients with myeloproliferative neoplasms. NeuVax is in clinical trials in breast cancer. GALE-301 and GALE-302 have completed early stage trials in ovarian, endometrial and breast cancers. | |
|
GALE (GALE) has the following price history information. Looking back at GALE historical stock prices for the last five trading days, on December 22, 2017, GALE opened at $0.28, traded as high as $0.28 and as low as $0.27, and closed at $0.28. Trading volume was a total of 730.60K shares. On December 26, 2017, GALE opened at $0.28, traded as high as $0.29 and as low as $0.27, and closed at $0.28. Trading volume was a total of 500.30K shares. On December 27, 2017, GALE opened at $0.28, traded as high as $0.29 and as low as $0.27, and closed at $0.28. Trading volume was a total of 577.40K shares. On December 28, 2017, GALE opened at $0.28, traded as high as $0.28 and as low as $0.27, and closed at $0.28. Trading volume was a total of 705.30K shares. On December 29, 2017, GALE opened at $0.29, traded as high as $0.40 and as low as $0.26, and closed at $0.26. Trading volume was a total of 20.35M shares.
GALE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into GALE shares, starting with a $10,000 purchase of GALE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
12/29/2017 |
|
Start price/share: |
$41.60 |
|
End price/share: |
$0.26 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.38% |
|
Average Annual Total Return: |
-74.72% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$62.52 |
|
Years: |
3.69 |
|
|
|
Date |
Close |
12/22/2017 | $0.28 | 12/26/2017 | $0.28 | 12/27/2017 | $0.28 | 12/28/2017 | $0.28 | 12/29/2017 | $0.26 |
|
|